Phenotypic and Functional Profiling of CD4 T Cell Compartment in Distinct Populations of Healthy Adults with Different Antigenic Exposure

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Roetynck, Sophie ^a   Olotu, Ally ^b   Simam, Joan ^b   Marsh, Kevin ^b,c   Stockinger, Brigitta ^a   Urban, Britta ^b,d   Langhorne, Jean ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPOSURE; FEASIBILITY STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KENYA; MALE; NORMAL HUMAN; PHENOTYPIC VARIATION; PILOT STUDY; RURAL AREA; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; URBAN AREA; URBAN RURAL DIFFERENCE; VALIDATION PROCESS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; KENYA; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; RURAL POPULATION; STATISTICS, NONPARAMETRIC;

EID: 84873878906     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055195     Document Type: Article

References (63)

1. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, et al. (2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421: 852-856.
2. Herrick CA, Bottomly K, (2003) To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 3: 405-412.
3. Tesmer LA, Lundy SK, Sarkar S, Fox DA, (2008) Th17 cells in human disease. Immunol Rev 223: 87-113.
4. Appay V, van Lier RA, Sallusto F, Roederer M, (2008) Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73: 975-983.
5. Sprent J, Surh CD, (2002) T cell memory. Annu Rev Immunol 20: 551-579.
6. Kaech SM, Wherry EJ, Ahmed R, (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2: 251-262.
7. Zinkernagel RM, Hengartner H, (2001) Regulation of the immune response by antigen. Science 293: 251-253.
8. Iezzi G, Karjalainen K, Lanzavecchia A, (1998) The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95.
9. Harari A, Vallelian F, Meylan PR, Pantaleo G, (2005) Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 174: 1037-1045.
10. O'Shea JJ, Paul WE, (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327: 1098-1102.
11. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, et al. (2003) Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 4: 78-86.
12. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639-646.
13. Seder RA, Darrah PA, Roederer M, (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8: 247-258.
14. Pantaleo G, Harari A, (2006) Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 6: 417-423.
15. Perfetto SP, Chattopadhyay PK, Roederer M, (2004) Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 4: 648-655.
16. Chattopadhyay PK, Roederer M (2005) Immunophenotyping of T cell subpopulations in HIV disease. Curr Protoc Immunol Chapter 12: Unit 12 12.
17. Zielinski CE, Corti D, Mele F, Pinto D, Lanzavecchia A, et al. (2011) Dissecting the human immunologic memory for pathogens. Immunol Rev 240: 40-51.
18. Mbogo CM, Mwangangi JM, Nzovu J, Gu W, Yan G, et al. (2003) Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg 68: 734-742.
19. Lanzavecchia A, Sallusto F, (2000) Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290: 92-97.
20. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
21. Palmer BE, Boritz E, Wilson CC, (2004) Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. J Immunol 172: 3337-3347.
22. Alexander TH, Ortiz GM, Wellons MF, Allen A, Grace EJ, 2nd, et al (2003) Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection. J Acquir Immune Defic Syndr 34: 475-481.
23. Bohler T, von Au M, Klose N, Muller K, Coulibaly B, et al. (2007) Evaluation of a simplified dual-platform flow cytometric method for measurement of lymphocyte subsets and T-cell maturation phenotypes in the population of Nouna, Burkina Faso. Clin Vaccine Immunol 14: 775-781.
24. Wherry EJ, (2011) T cell exhaustion. Nat Immunol 12: 492-499.
25. Kassu A, Tsegaye A, Petros B, Wolday D, Hailu E, et al. (2001) Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin Diagn Lab Immunol 8: 1171-1176.
26. Chuma J, Gilson L, Molyneux C, (2007) Treatment-seeking behaviour, cost burdens and coping strategies among rural and urban households in Coastal Kenya: an equity analysis. Trop Med Int Health 12: 673-686.
27. Messele T, Abdulkadir M, Fontanet AL, Petros B, Hamann D, et al. (1999) Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 115: 443-450.
28. Mordmuller BG, Metzger WG, Juillard P, Brinkman BM, Verweij CL, et al. (1997) Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw 8: 29-35.
29. Kremsner PG, Winkler S, Brandts C, Wildling E, Jenne L, et al. (1995) Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg 53: 532-538.
30. Pfeffer K, (2003) Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 14: 185-191.
31. Bejon P, Mwangi TW, Lowe B, Peshu N, Hill AV, et al. (2008) Helminth infection and eosinophilia and the risk of Plasmodium falciparum malaria in 1- to 6-year-old children in a malaria endemic area. PLoS Negl Trop Dis 2: e164.
32. Borkow G, Leng Q, Weisman Z, Stein M, Galai N, et al. (2000) Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 106: 1053-1060.
33. Bentwich Z, Kalinkovich A, Weisman Z, Grossman Z, (1998) Immune activation in the context of HIV infection. Clin Exp Immunol 111: 1-2.
34. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
35. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, et al. (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9: 1341-1346.
36. Pullan RL, Gething PW, Smith JL, Mwandawiro CS, Sturrock HJ, et al. (2011) Spatial modelling of soil-transmitted helminth infections in Kenya: a disease control planning tool. PLoS Negl Trop Dis 5: e958.
37. Walson JL, Stewart BT, Sangare L, Mbogo LW, Otieno PA, et al. (2010) Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults. PLoS Negl Trop Dis 4: e644.
38. Nogaro SI, Hafalla JC, Walther B, Remarque EJ, Tetteh KK, et al. (2011) The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission. PLoS One 6: e25582.
39. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, et al. (2008) Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 76: 2240-2248.
40. Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, et al. (2006) High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 24: 4233-4246.
41. Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, et al. (2004) Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23: 718-728.
42. Olotu A, Fegan G, Wambua J, Nyangweso G, Ogada E, et al. (2012) Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS One 7: e32929.
43. Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, et al. (2004) Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 42: 5636-5643.
44. Chelimo K, Embury PB, Sumba PO, Vulule J, Ofulla AV, et al. (2011) Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1. PLoS One 6: e24852.
45. Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, et al. (2012) Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 13: 188-195.
46. Riley EM, Morris-Jones S, Blackman MJ, Greenwood BM, Holder AA, (1993) A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission. Parasite Immunol 15: 513-524.
47. Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, et al. (2009) Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog 5: e1000364.
48. Gitau EN, Tuju J, Stevenson L, Kimani E, Karanja H, et al. (2012) T-cell responses to the DBLalpha-tag, a short semi-conserved region of the Plasmodium falciparum membrane erythrocyte protein 1. PLoS One 7: e30095.
49. Freitas do Rosario AP, Lamb T, Spence P, Stephens R, Lang A, et al. (2012) IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol 188: 1178-1190.
50. O'Garra A, Vieira P, (2007) T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7: 425-428.
51. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, et al. (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A 102: 5108-5113.
52. Geiger R, Duhen T, Lanzavecchia A, Sallusto F, (2009) Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 206: 1525-1534.
53. De Rosa SC, Lu FX, Yu J, Perfetto SP, Falloon J, et al. (2004) Vaccination in humans generates broad T cell cytokine responses. J Immunol 173: 5372-5380.
54. Uzonna JE, Wei G, Yurkowski D, Bretscher P, (2001) Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J Immunol 167: 6967-6974.
55. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
56. Chuma J, Molyneux C, (2009) Estimating inequalities in ownership of insecticide treated nets: does the choice of socio-economic status measure matter? Health Policy Plan 24: 83-93.
57. Trager W, Jensen JB, (1976) Human malaria parasites in continuous culture. Science 193: 673-675.
58. Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, et al. (1992) Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357: 689-692.
59. Horrocks P, Pinches R, Christodoulou Z, Kyes SA, Newbold CI, (2004) Variable var transition rates underlie antigenic variation in malaria. Proc Natl Acad Sci U S A 101: 11129-11134.
60. Tang J, Hu M, Lee S, Roblin R, (2000) A polymerase chain reaction based method for detecting Mycoplasma/Acholeplasma contaminants in cell culture. J Microbiol Methods 39: 121-126.
61. Ndungu FM, Olotu A, Mwacharo J, Nyonda M, Apfeld J, et al. (2012) Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc Natl Acad Sci U S A 109: 8247-8252.
62. Mahnke YD, Roederer M (2007) Optimizing a multicolor immunophenotyping assay. Clin Lab Med 27: 469-485, v.
63. Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, et al. (2010) Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. J Immunol Methods 363: 42-50.